[1]
Q. Jing, “Breast Cancer CDK4/6 Inhibitor Resistance and Immunotherapy Strategies”, IJBLS, vol. 16, no. 1, pp. 83–88, Aug. 2026, doi: 10.54097/6gx2f812.